company_name,company_legal_names,company_commercial_names,main_country_code,main_region,main_city_district,main_city,main_postcode,main_street,main_street_number,main_latitude,main_longitude,main_address_raw_text,locations,short_description,long_description,business_tags,product_type,main_industry,main_sector,primary_phone,phone_numbers,primary_email,emails,other_emails,website_url,website_domain,website_language_code,facebook_url,twitter_url,instagram_url,linkedin_url,ios_app_url,android_app_url,youtube_url,generated_description,generated_business_tags,domains,id
celyad oncology's,celyad oncology sa.,celyad oncology's | celyad oncology | celyad,be,walloon brabant,,mont-saint-guibert,1435,rue andré dumont,9,50.65745355,4.628050735565999,axis business park rue andré dumont 9 1435 mont-saint-guibert belgium,"be, belgium, walloon brabant, mont-saint-guibert, 1435, rue andré dumont, 9, 50.65745355, 4.628050735565999","celyad oncology's is a biotechnology company based in mont-saint-guibert, belgium.","celyad oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (car) t-cells. its primary objective is to unlock the potential of its proprietary technology platforms and intellectual property, enabling to be at the forefront of developing next-generation car t-cell therapies. celyad oncology's headquarters are located in mont-saint-guibert, belgium. by fully leveraging our innovative technology platforms, we aim to maximize the transformative impact of our candidate car t-cell therapies and technologies to redefine the future of car t-cell treatments. our goal is to provide solutions to tackle the current limitations of car t-cell therapies by using proprietary technologies and targeting a broad range of indications. to achieve this goal we aim to leverage our in-house knowledge and form strategic alliances. more info about celyad oncology. our differentiated strategy includes the development of technology platforms and car t-cell candidates to broaden the range of cancer indications and tackle the main limitations of current car t-cell therapies.",business highlights | services & help | statistics & data | advertising spaces | search engine | biotechnology | cell therapy | sec reporting | intellectual property | change & innovating | oncology,professional services,research & development services,other professional services,+18579906900,+18579906900 | +3210394141 | +3210394100,job@celyad.com,job@celyad.com | info@celyad.com | privacy@celyad.com,,,celyad.com,en,,CelyadSA,,company/celyad,,,,"celyad, legally known as celyad sa., headquartered in mont-saint-guibert, walloon brabant, is a clinical-stage biotechnology company focused on discovering and developing chimeric antigen receptor (car) t-cell therapies for cancer. the company leverages proprietary technology platforms and intellectual property to advance its candidate car t-cell therapies, aiming to address the limitations of current car t-cell therapies and expand the range of cancer indications. celyad's strategy includes the development of technology platforms and car t-cell candidates to redefine the future of car t-cell treatments.",car-t cell therapists | biotechnology research and development | intellectual property utilization | chimeric antigen receptor t cells | proprietary technology platform | strategic alliances | clinical-stage biotechnology company,celyad.com | celyad.org | celyad.asia,1862
